Advanced search
Publication Cover
Immunological Medicine Volume 41, 2018 - Issue 1
Submit an article Journal homepage
1,772
Views
0
CrossRef citations to date
0
Altmetric
Review Article

New horizons in clinical immunology: applications of induced pluripotent stem cells for the analysis of immune disorders

Hirofumi ShodaDepartment of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, JapanCorrespondence[email protected]
,
Bunki NatsumotoDepartment of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
&
Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
Pages 12-16 | Received 18 Jan 2018, Accepted 08 Mar 2018, Published online: 04 Apr 2018

References

  • Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–156.
  • Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA. 1981;78:7634–7638.
  • Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147.
  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676.
  • Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult fibroblasts by defined factors. Cell. 2007;131:861–872.
  • Hasegawa H, Kawahata K, Mizoguchi F, et al. Direct suppression of autoaggressive CD8+ T cells with CD80/86 blockade in CD8+ T cell-mediated polymyositis models of mice. Clin Exp Rheumatol. 2017;35:593–597.
  • Yamamoto K, Okada Y, Suzuki A, et al. Genetics of rheumatoid arthritis in Asia–present and future. Nat Rev Rheumatol. 2015;11:375–379.
  • Natsumoto B, Shoda H, Fujio K, et al. Investigation of the pathogenesis of autoimmune diseases by iPS cells. Jpn J Clin Immun. 2017;40:48–53.
  • Yusa K, Rashid ST, Strick-Marchand H, et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cell. Nature. 2011;478:391–394.
  • Flynn R, Grundmann A, Renz P, et al. CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells. Exp Hematol. 2015;43:838–848.
  • Choi KD, Vodyanik MA, Slukvin II. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34 + CD43 + CD45 progenitors. J Clin Invest. 2009;119:2818–2829.
  • Senju S, Haruta M, Matsumura K, et al. Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy. Gene Ther. 2011;18:874–883.
  • Masakatsu D, Niwa A, Tanaka T, et al. Rubust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions. Pros One. 2013;8:e59243.
  • Iizuka-Koga M, Asashima H, Ando M, et al. Functional analysis of dendritic cells generated from t-ipscs from CD4+ T cell clones of Sjögren's syndrome. Stem Cell Rep. 2017;8:1155–1163.
  • McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133–144.
  • Bentham J, Morris DL, Cunninghame Graham DS, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47:1457–1464.
  • van Wilgenburg B, Browne C, Vowles J, et al. Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS One. 2013;8:e71098.
  • Knorr DA, Kaufman DS. Pluripotent stem cell-derived natural killer cells for cancer therapy. Transl Res. 2010;156:147–154.
  • Knorr DA, Ni Z, Hermanson D, et al. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med. 2013;2:274–283.
  • Kitayama S, Zhang R, Liu T-Y, et al. Cellular adjuvant properties, direct cytotoxicity of re-differentiated Vα24 invariant NKT-like cells from human induced pluripotent stem cells. Stem Cell Rep. 2016;6:213–227.
  • Yamada D, Iyoda T, Vizcardo R, et al. Efficient regeneration of human Vα24+ invariant natural killer T cells and their anti-tumor activity in vivo. Stem Cells. 2016;34:2852–2860.
  • Nishimra T, Kaneko S, Kawana-Tachikawa A, et al. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell. 2013;12:114–126.
  • Vizcardo R, Masuda K, Yamada D, et al. Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8+ T cells. Cell Stem Sell. 2013;12:31–36.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.